Assembly Biosciences
ASMB
46 hedge funds and large institutions have $61.1M invested in Assembly Biosciences in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 5 closing their positions.
138% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 48 → 46 (-2)
34% less capital invested
Capital invested by funds: $92.3M → $61.1M (-$31.1M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
+$1.15M |
| 2 |
DCM
Dialectic Capital Management
Norwalk,
Connecticut
|
+$317K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$286K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$181K |
| 5 |
Renaissance Technologies
New York
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.48M |
| 2 |
IHM
Iguana Healthcare Management
New York
|
-$1.13M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$113K |
| 4 |
Millennium Management
New York
|
-$106K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$91.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| – | -$3K | -28 | Closed |
|
ASMB Hedge Fund Activity: Q1 2016 in Review
46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2016, worth a combined $61.1M — down 34% from $92.3M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ASMB and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 19 added.
The largest buyer was QVT Financial, adding an estimated $1.15M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.48M sold.
- 46 institutional investors held Assembly Biosciences (ASMB) as of Q1 2016, down from 48 in Q4 2015.
- Funds reported $61.1M of Assembly Biosciences stock for Q1 2016, down 34% quarter-over-quarter.
- 3 funds opened new Assembly Biosciences positions in Q1 2016 and 5 closed out, a net change of -2 holders.
- The largest Assembly Biosciences buyer in Q1 2016 was QVT Financial, an estimated $1.15M added.
- The largest Assembly Biosciences seller in Q1 2016 was Fidelity Investments, an estimated $1.48M sold.
Based on aggregated 13F filings for Q1 2016.